BioSpace News Archive

XORTX Therapeutics Inc., a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that Mr. Amar Keshri will join the XORTX management team in the role of Chief Financial Officer replacing James Fairbairn, the Company’s current Chief Financial Officer.

atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects, announced the successful treatment of the first five patients in its ASCENT ASD U.S. Investigational Device Exemption pivotal trial.

Cellares Corporation, a life sciences technology company pioneering a revolutionary automated approach to cell therapy manufacturing, announced that Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, has joined its Early Access Partnership Program.

Ribon Therapeutics announced the closing of a $65 million financing.

BriaCell Therapeutics Corp. today announces the open recruitment and enrollment of their collaborative clinical study with Incyte.

Vera Therapeutics, Inc. today announced the appointment of Sean Grant, MBA as Chief Financial Officer.

Entos, Inc today announced the closing of a $53 million Series A financing round led by Coatue, a leading technology investment firm, and Catalio Capital Management

JATT Acquisition Corp (the “Company”), a newly organized blank check company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 12 million units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant.

NEC Corporation announced the development of an AI technology for supporting doctors in determining if colorectal lesions are neoplastic or non-neoplastic.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021.